Medspira to Debut Breath Hold Respiration Monitoring System at RSNA 2011

October 3, 2011 — Medspira will introduce Breath Hold, a standalone system for respiration monitoring during radiation therapy (RT) treatments, at RSNA 2011. The device is specifically designed for treatments involving the lungs and upper abdomen. It enables patients to accurately self-monitor their breathing patterns based on biofeedback delivered by the device’s simple visual display.

Breath Hold represents a non-intrusive way to promote predictable breath hold and breathing patterns, enabling precise targeting of tissue affected by respiratory motion. It will enable a far greater number of sites to effectively address the problems of motion due to patient free breathing during radiation treatments involving the lungs and upper abdomen, particularly treatments of the left breast.

The new device complements Medspira’s existing Breath Hold technology for image guided biopsies and other applications in which respiratory motion is an issue.

The device incorporates an expandable bellows system and a pressure sensitive transducer tube, which is wrapped around the patient’s chest or stomach. During the treatment, patients watch an LED monitor, which presents their breathing pattern as a series of lights. A reference point, typically either an inhale or exhale, is selected to help the patient establish a consistent light pattern on the LED display.

For more information: www.medspira.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
Subscribe Now